Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
13-bis((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-4-((2S
InChiKey: WDWZBAMDKXKRBA-UHFFFAOYSA-N
6H05 can be used as an intermediate for the synthesis of other oncogenic K-Ras(G12C) inhibitors
InChiKey: BLFQGGGGFNSJKA-XHXSRVRCSA-N
Smiles: CC(C)(C)OC(=O)COCCOCCOCCOCCON
PKR-IN-2 Size:Contact [email protected] for quotation 13-bis((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-4-((2SPKR IN 2 is a pyruvate kinase isoform PKR activator extracted from patent WO2014139144A1, compound 160. PKR IN 2 can be used for the research of PKR function related diseases, including cancer, diabetes, obesity, autoimmune disorders, and benign prostatic hyperplasia. Product information CAS Number: 1628428 01 2 Molecular Weight: 468. 57 Formula: C24H28N4O4S Chemical Name: N {4 [4 hydroxy 4 (2 methylpropyl)piperidine 1 carbonyl]phenyl}quinoxaline 5
US$ 372.50
US$ 197.00
US$ 234.00
US$ 119.00